The latest price target for AngioDynamics (NASDAQ:ANGO) was reported by Freedom Broker on April 6, 2026. The analyst firm set a price target for $16.00 expecting ANGO to rise to within 12 months (a possible 44.53% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for AngioDynamics (NASDAQ:ANGO) was provided by Freedom Broker, and AngioDynamics initiated their buy rating.

The last upgrade for AngioDynamics Inc happened on April 5, 2024 when Oppenheimer raised their price target to $12. Oppenheimer previously had a perform for AngioDynamics Inc.

There is no last downgrade for AngioDynamics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AngioDynamics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AngioDynamics was filed on April 6, 2026 so you should expect the next rating to be made available sometime around April 6, 2027.

While ratings are subjective and will change, the latest AngioDynamics (ANGO) rating was a initiated with a price target of $0.00 to $16.00. The current price AngioDynamics (ANGO) is trading at is $11.07, which is within the analyst’s predicted range.